Side Effects of Medications for Nightmares
Prazosin is generally well-tolerated with the most common side effects being orthostatic hypotension, dizziness, and transient lightheadedness, while most other medications used for nightmares carry more significant adverse effect profiles including sedation, metabolic effects, and extrapyramidal symptoms.
Prazosin Side Effects
Based on the American Academy of Sleep Medicine guideline 1, prazosin demonstrates a favorable safety profile across multiple trials:
Common side effects:
- Orthostatic hypotension and dizziness - the most frequently reported adverse events 2
- Transient dizziness (reported in 18% of pediatric patients) 3
- First-dose hypotension requiring careful titration 4
- Risk of syncope, particularly in elderly patients
Important tolerability findings:
- In multiple RCTs, "no significant blood pressure changes or other side effects were noted" at lower doses 1
- Only two subjects in one study experienced mild orthostatic systolic blood pressure reductions that resolved during treatment 1
- "Prazosin was generally well-tolerated except for several subjects who experienced transient dizziness; there were no falls or syncopal episodes" 1
Rare paradoxical effects:
- One case report documented prazosin actually causing nightmares and sleep disturbances in an elderly patient, though this is extremely uncommon 5
- Headaches (6% in pediatric population) 3
- Anxiety (9% in pediatric population) 3
Clinical pearls for prazosin:
- Start low and titrate slowly to minimize orthostatic effects
- Monitor blood pressure, especially after first dose and dose increases
- Particular caution in elderly patients who may be more susceptible to hypotensive effects
- The medication is generally well-tolerated with adverse events consistent with its alpha-1 blocking mechanism 3
Atypical Antipsychotics Side Effects
Olanzapine
Based on comparative data 6:
- Sedation is the primary side effect (28.6% of patients)
- Metabolic effects including weight gain, hyperglycemia, and dyslipidemia (from general medical knowledge)
- Lower risk of extrapyramidal symptoms compared to typical antipsychotics
Risperidone
From the comparative study 6:
- Extrapyramidal symptoms (4.8% of cases) - lower than haloperidol but still present
- Hyperprolactinemia with associated sexual dysfunction and galactorrhea
- Weight gain and metabolic effects
- Sedation (though less than olanzapine)
Aripiprazole
The FDA label 7 provides comprehensive safety data:
Common adverse reactions (≥5% in overdose cases):
- Vomiting
- Somnolence
- Tremor
Serious adverse reactions from overdose/toxicity:
- Cardiovascular: atrial fibrillation, bradycardia, hypertension, hypotension, QT prolongation, tachycardia
- Neurological: convulsion, status epilepticus, lethargy, loss of consciousness, coma
- Metabolic: hypokalemia, elevated creatine phosphokinase
- Respiratory: aspiration pneumonia, respiratory arrest
Clinical considerations:
- Highly protein-bound (hemodialysis ineffective in overdose)
- Generally better metabolic profile than olanzapine or risperidone
- Lower sedation compared to other atypicals
Benzodiazepines Side Effects
Triazolam
The FDA label 8 provides detailed safety information:
Most common side effects (>5%):
- Drowsiness (14% of patients) - the most frequent adverse effect
- Headache (9.7%)
- Dizziness (7.8%)
- Nervousness (5.2%)
- Lightheadedness (4.9%)
- Coordination disorders/ataxia (4.6%)
- Nausea/vomiting (4.6%)
Serious behavioral effects:
- Complex sleep behaviors (sleep-walking, sleep-driving, engaging in activities while not fully awake)
- Anterograde amnesia, including "traveler's amnesia"
- Paradoxical reactions: agitation, aggression, hallucinations, mania, restlessness
- Worsening of depression and suicidal thoughts
- Abnormal thinking and behavior changes
Withdrawal symptoms (1-2 days after discontinuation):
- Rebound insomnia
- Unpleasant feelings
- Stomach and muscle cramps
- Vomiting, sweating, shakiness
- Seizures (in severe cases)
Critical warnings:
- Elderly patients are "especially susceptible to dose-related adverse effects"
- Risk of dependence and abuse (Schedule IV controlled substance)
- Contraindicated with potent CYP3A inhibitors (ketoconazole, itraconazole, nefazodone)
Nitrazepam
While not specifically detailed in the provided evidence, this benzodiazepine shares the class effects of triazolam including sedation, cognitive impairment, dependence risk, and withdrawal symptoms.
Other Medications
Clonidine
Not specifically detailed in the provided evidence, but from general medical knowledge:
- Hypotension and bradycardia
- Sedation and fatigue
- Dry mouth
- Rebound hypertension with abrupt discontinuation
Nabilone (Synthetic Cannabinoid)
The meta-analysis 9 showed nabilone had the highest effect size (g = 1.86) for nightmare reduction, but specific side effect data was not provided in the evidence. From general knowledge:
- Dizziness and drowsiness
- Dry mouth
- Euphoria or dysphoria
- Cognitive impairment
Gabapentin
Not detailed in provided evidence. From general knowledge:
- Sedation and dizziness
- Peripheral edema
- Weight gain
- Ataxia
Cyproheptadine
Mentioned in the guideline 1 but specific side effect data not provided. From general knowledge:
- Sedation (antihistamine effect)
- Dry mouth
- Weight gain and increased appetite
- Dizziness
Topiramate
The guideline 1 mentions topiramate but provides limited side effect data. From general knowledge:
- Cognitive slowing ("dopamax")
- Paresthesias
- Weight loss
- Metabolic acidosis
- Kidney stones
- Acute angle-closure glaucoma (rare but serious)
Fluvoxamine & Trazodone
Not specifically detailed in provided evidence for nightmare treatment context.
Clinical Decision-Making Algorithm
For selecting medication based on side effect profile:
First-line: Prazosin - best evidence base, most favorable side effect profile limited primarily to orthostatic hypotension 1, 4
If prazosin contraindicated or ineffective:
- Consider alternative alpha-1 blockers (doxazosin, terazosin) 10
- Monitor blood pressure carefully
If alpha-blockers fail or contraindicated:
Avoid benzodiazepines as first-line due to dependence risk, complex sleep behaviors, and paradoxical reactions 8
Key monitoring parameters:
- Blood pressure (standing and supine) for alpha-blockers
- Weight and metabolic parameters for antipsychotics
- Cognitive function and falls risk in elderly
- Signs of dependence with benzodiazepines
- Emergence of paradoxical worsening of nightmares or new psychiatric symptoms